30-Day Dynamic Summary

Azure A.

January 7 – February 5, 2026

72/100
+4 pts

vs. previous 30 days

📈 Biometric Trends

Resting Heart Rate

→ Stable
72 bpm

Baseline: 70 bpm

HRV

↑ Improving
38 ms

Baseline: 42 ms

Sleep Duration

↓ Declining
6.2 hrs

Baseline: 7.0 hrs

SpO2

→ Stable
96.2%

Baseline: 96.5%

Activity (Steps)

↓ Declining
5,840

Baseline: 7,000

Stress Events

⚠ Elevated
14

Baseline: 8-10/mo

🔥 Condition Flare Summary

POTS6 episodes
↑ Improving

Down from 9 last month. Correlated with sleep deficit and dehydration.

RRMS2 episodes
→ Stable

Fatigue and cognitive fog episodes. Both followed high-stress work days.

MCAS3 episodes
↑ Improving

Triggers identified: travel (2), new environment (1). Antihistamine timing adjusted.

Raynaud's8 episodes
→ Stable

Cold-triggered episodes. Office temperature correlation confirmed.

ADHD0 episodes
→ Stable

Medication adherence at 92%. Focus sessions improved with schedule restructuring.

🔗 Patterns Discovered This Month

Back-to-Back Meetings → POTS Flare

91% confidence

4+ hours of consecutive meetings without movement break triggers POTS episode within 2 hours. Occurs 87% of the time.

⚠ Trigger

Timezone Shift → 72hr Recovery Window

84% confidence

NY ↔ QLD travel requires 72 hours for HRV to return to baseline. Planning buffer days reduces flare risk by 60%.

🔄 Recovery

Evening Email → Sleep Disruption

78% confidence

Checking work email after 8 PM correlates with 40-minute sleep onset delay and 18% less REM sleep.

⚠ Trigger

Morning Hydration → POTS Prevention

88% confidence

500ml water + electrolytes before 8 AM reduces POTS episodes by 65% on that day.

🛡 Protective

Co-parenting Schedule → Cortisol Spike

82% confidence

Transition days show 34% elevated cortisol for 6+ hours. Pre-transition meditation reduces impact by 40%.

⚠ Trigger

💊 Medication Insights

Beta blocker timing optimization

Taking propranolol 30 minutes before known stressful meetings reduces HR spike by 22%.

Antihistamine + fatigue correlation

Cetirizine taken after 11 AM correlates with afternoon drowsiness. Morning dosing (before 9 AM) shows no fatigue impact.

Vitamin D adherence gap

Missed on 38% of days. Correlates with 1.8-point evening energy drop. Consider morning pairing with existing meds.

🔮 Active Predictions

POTS flare likely Feb 8-9

87% confidence

Heavy meeting schedule + recent travel + declining HRV trend

Sleep quality improvement expected

74% confidence

No travel planned for 10 days. Historically, sleep normalizes within 5 days of stable routine.

MCAS trigger risk: low

81% confidence

No environmental changes planned. Antihistamine adherence strong.

🩺 Appointment Preparation

February 12, 2026 — Dr. Chen (Neurologist)

Suggested discussion topics based on your 30-day data:

  1. 1.HRV trending below baseline (38ms vs 42ms) — discuss disease-modifying therapy efficacy
  2. 2.2 RRMS fatigue episodes correlated with work stress — request cognitive assessment
  3. 3.Sleep duration declining (6.2 hrs avg) — discuss sleep hygiene protocol
  4. 4.Medication interaction: antihistamine timing affects afternoon cognition

This is a sample 30-day summary. Real summaries are generated from your connected data sources.